Medicine News and Research

RSS

Duke Medicine creates DCHI to provide campus focus for health informatics

In response to the increasingly critical role of healthcare information technologies in the evolving healthcare delivery system, Duke Medicine has created the Duke Center for Health Informatics (DCHI) to provide a campus focus for health informatics.

4 Dec 2009

Majority of Canadians living with diabetes do not receive all clinical tests from health providers

While most Canadian adults living with diabetes get regular care, they are not always getting all of the clinically recommended tests they require to prevent health complications.

4 Dec 2009

Genetic differences determine intensity of people's responses to social rejection

Scientists have long known that opium-like painkillers, called opioids, relieve not only physical pain, but also some forms of emotional stress. Now, a new study reviewed by Faculty of 1000 Biology member Markus Heilig shows that small genetic differences in the gene for the opioid receptor can determine the intensity of people's responses to social rejection.

4 Dec 2009

Researchers discover new strategy against invasive parasite

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a possible strategy against an invasive parasite that infects more than a quarter of the world's population, including 50 million Americans.

4 Dec 2009

Combination of green tea and DAPH-12 chemicals may help prevent brain disorders

Scientists at Boston Biomedical Research Institute (BBRI) and the University of Pennsylvania have found that combining two chemicals, one of which is the green tea component EGCG, can prevent and destroy a variety of protein structures known as amyloids. Amyloids are the primary culprits in fatal brain disorders such as Alzheimer's, Huntington's, and Parkinson's diseases.

4 Dec 2009

New biochemical probe may help in identifying toxic proteins associated with Alzheimer's disease

Alzheimer's disease (AD) is one of the most heartbreaking diagnoses a person can receive. This irreversible, progressive brain disease slowly destroys memory and thinking skills and eventually even the ability to carry out the simplest tasks

4 Dec 2009

Geisinger Health System and Philips VISICU team up to launch eICU Program

Geisinger Health System recently signed an agreement with Philips VISICU, to launch an eICU Program® that will enhance physicians' ability to care for Geisinger's sickest patients.

4 Dec 2009

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.

3 Dec 2009

American Pain Society supports FDA drug disposal guidelines

Calling it "an important first step in attempting to reverse an escalating public health menace caused by diversion of prescription opioid pain medications," the American Pain Society today announced its support for a new FDA initiative to encourage consumers to remove unused pain drugs from home medicine cabinets.

3 Dec 2009

Study shows younger, female and Hispanic stroke survivors are less likely to take antithrombotic medications

People who have had an ischemic stroke are at higher lifetime risk for another stroke, but several types of medication can reduce that risk. One of the simplest regimens involves antithrombotic medications, otherwise known as blood thinners, of which the most common is aspirin.

3 Dec 2009

Last patient visit complete in VIA Pharmaceuticals' Phase 2 FDG-PET trial

VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that it has completed the last patient visit in its Phase 2 FDG-PET clinical trial of VIA-2291.

3 Dec 2009

Today's opinions and editorials

Defenders of the status quo in health care would happily let the drive for reform bog down amid a debate over President Obama's new war strategy. Democrats can't let this happen (12/3).

3 Dec 2009

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Rules-Based Medicine, Inc. (RBM) today announced that Psynova Neurotech Limited (Cambridge UK), a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.

3 Dec 2009

Global HIV reporting and monitoring system provides good indication of overall progress towards HIV goal

Although much work remains to be done, a United Nations global reporting system on HIV/AIDS has already yielded an "unequaled wealth of data" on progress toward meeting UN targets for responding to the global HIV epidemic.

3 Dec 2009

UK DFID awards CNTD £10M in elimination of elephantiasis initiative

The Centre for Neglected Tropical Diseases (CNTD) at the Liverpool School of Tropical Medicine has been awarded £10 million by the UK Department for International Development (DFID) to support endemic countries in tackling lymphatic filariasis (LF) - a crippling disease more commonly known as elephantiasis.

3 Dec 2009

New study sheds light on feeding challenges faced by premature infants

A recent study conducted by researchers and physicians at Nationwide Children's Hospital sheds new light on feeding challenges often faced by premature infants. Although the prevalence of this disorder is well recognized, the feeding milestones for infants have not been well described.

3 Dec 2009

Analysis shows fewer victims survive out-of-hospital cardiac arrests

The chance of surviving an out-of-hospital cardiac arrest has not improved since the 1950s, according to a report by the University of Michigan Health System.

3 Dec 2009

PEG polymer may prevent GI injury during cancer radiotherapy

A non-absorbed, oral co-polymer therapy under development by Midway Pharmaceuticals demonstrated the ability to protect against damage to healthy gastrointestinal tissues and to prevent lethal bacterial infections in animal models of radiation damage.

3 Dec 2009

EU study to promote health and reduce risk-taking and self-destructive behavior in young people

At the beginning of 2010, the Child and Adolescent Psychiatry Department at the Center for Psychosocial Medicine at Heidelberg University Hospital will conduct a study named "Saving and Empowering Young Lives in Europe (SEYLE) - promoting the health of young people through the prevention of risk-taking and self-destructive behavior" in cooperation with twelve centers in other EU countries and Israel.

3 Dec 2009

TGen scientists win $1,000 prize for best scientific paper presented at BIBM09

A team of scientists at the Translational Genomics Research Institute (TGen) won a $1,000 prize for best scientific paper presented at BIBM09, a premier bioinformatics and biomedicine conference.

3 Dec 2009

Medicine News and Research

Duke Medicine creates DCHI to provide campus focus for health informatics

Majority of Canadians living with diabetes do not receive all clinical tests from health providers

Genetic differences determine intensity of people's responses to social rejection

Researchers discover new strategy against invasive parasite

Combination of green tea and DAPH-12 chemicals may help prevent brain disorders

New biochemical probe may help in identifying toxic proteins associated with Alzheimer's disease

Geisinger Health System and Philips VISICU team up to launch eICU Program

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

American Pain Society supports FDA drug disposal guidelines

Study shows younger, female and Hispanic stroke survivors are less likely to take antithrombotic medications

Last patient visit complete in VIA Pharmaceuticals' Phase 2 FDG-PET trial

Today's opinions and editorials

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Global HIV reporting and monitoring system provides good indication of overall progress towards HIV goal

UK DFID awards CNTD £10M in elimination of elephantiasis initiative

New study sheds light on feeding challenges faced by premature infants

Analysis shows fewer victims survive out-of-hospital cardiac arrests

PEG polymer may prevent GI injury during cancer radiotherapy

EU study to promote health and reduce risk-taking and self-destructive behavior in young people

TGen scientists win $1,000 prize for best scientific paper presented at BIBM09

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News